' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Steinhoff, BJ; Trinka, E; Wendling, AS;
Nervenarzt. 2011; 82(6): 764-767.
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

Trinka Eugen

Abstract

Eslicarbazepine acetate (ESL) was labelled for add-on treatment of adults with focal epilepsies in 2009. ESL is a derivative of carbamazepine and oxcarbazepine (OXC) that promises potentially better effectiveness. It has not yet been investigated how to switch from OXC to ESL and if this switch causes any clinical changes.


Useful keywords (using NLM MeSH Indexing)

Adult

Anticonvulsants/administration*

dosage*

Carbamazepine/administration*

dosage

Carbamazepine/analogs*

derivatives*

Delayed-Action Preparations

Dibenzazepines/administration*

dosage*

Drug Therapy, Combination

Epilepsy/drug therapy*

Female

Humans

Male

Middle Aged

Treatment Outcome

Young Adult


Find related publications in this database (Keywords)

Oxcarbazepine
Eslicarbazepine acetate
Epilepsy
Safety
Tolerability